Table 1.
Summary of viruses on plastic surfaces.
| Virus type | Strain | Final viral titer TCID50/mL | Temperature/°C | Relative humidity/% | Persistence/h | Reference |
|---|---|---|---|---|---|---|
| SARS-CoV-1 | HKU39849 | 106 | 22–25 | 40–50 | > 72 | [64] |
| CoV–P9 | NA | 20 | NA | ∼72 | [65] | |
| Isolate FFM1 | <102 | 21–25 | NA | ∼216 | [66] | |
| AY274119.3 | 100.7 | 21–23 | 40 | ∼72 | [62] | |
| SARS-CoV-2 | NA | 2.27 ± 0.09 | 22 | 65 | 96 | [67] |
| MN985325.1 | <1 | 23 | 40 | 72 | [62] | |
| Influenza virus | A/Brazil/11/78-like, H1N1 | 1 | 26.7–28.9 | 55–56 | 48 | [61] |
| B/Illinois/1/79-like | ||||||
| Adapted A/Puerto Rico/8/34 | 102 | 17–21 | 23–24 | ∼4 | [68] | |
| Isolate A/Cambridge/AH04/2009 | ||||||
| MERS-CoV | Isolate HCoV-EMC/2012 | <1 | 20 | 20–40 | 48 | [69] |
| Human coronavirus | Human coronavirus 229E | <1 | 21 | 30–40 | 120 | [70] |
SARS-CoV-1, severe acute respiratory syndrome coronavirus1; SARS-CoV-2, severe acute respiratory syndrome coronavirus2; MERS-CoV, Middle East respiratory syndrome coronavirus; TCID50, tissue-culture infectious dose; NA, not available.